Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Werner syndrome provides a convincing model for aspects of the normal ageing phenotype and may provide a suitable model for therapeutic interventions designed to combat the ageing process. Cultured primary fibroblast cells from Werner syndrome patients provide a powerful model system to study the link between replicative senescence in vitro and in vivo pathophysiology. Genome instability, together with an increased pro-oxidant state, and frequent replication fork stalling, all provide plausible triggers for intracellular stress in Werner syndrome cells, and implicates p38 MAPK signaling in their shortened replicative lifespan. A number of different p38 MAPK inhibitor chemotypes have been prepared rapidly and efficiently using microwave heating techniques for biological study in Werner syndrome cells, including SB203580, VX-745, RO3201195, UR-13756 and BIRB 796, and their selectivity and potency evaluated in this cellular context. Werner syndrome fibroblasts treated with a p38 MAPK inhibitor reveal an unexpected reversal of the accelerated ageing phenotype. Thus the study of p38 inhibition and its effect upon Werner pathophysiology is likely to provide new revelations into the biological mechanisms operating in cellular senescence and human ageing in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaziri, H., & Benchimol, S. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70109-5 · Cited by 1,003 · cited 1×
“Cellular senescence in normal human fibroblasts appears to be triggered by telomere erosion [42-45].”
BackgroundEssential role of limiting telomeres in the pathogenesis of Werner syndrome
Chang, S., Multani, A. S., Cabrera, N. G., Naylor, M. L., Laud, P., Lombard, D., Pathak, S., Guarente, L., & DePinho, R. A. (2004) · Nature Genetics · doi:10.1038/ng1389 · Cited by 462 · cited 1×
“The suppression of this accelerated ageing by SB203580 suggests a route whereby WS may be amenable to therapeutic intervention, and the recent development of a fully reflective mouse model of WS makes future in vivo studies possible to ascertain whether p38 inhibitors could be effective as therapeutic agents in a prem…”
BackgroundWang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376 · cited 6×
“This class of compounds utilize binding interactions on the kinase that are spatially distinct from the adenosine 5′-triphosphate (ATP) pocket [105] stabilizing a conformation of the kinase that is incompatible with ATP binding, preventing the interaction of p38α with its upstream activating kinases MKK3 and MKK6 [118…”
BackgroundInfluentialDNA damage and repair in telomeres: relation to aging
Kruk, P. A., Rampino, N. J., & Bohr, V. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.258 · Cited by 333 · cited 1×
“Recent studies suggest WRNp participates in pathways at telomeric ends and WS cells display some defects in telomere metabolism, including increased apparent rates of telomere shortening [34] (although this has been argued to be an artifact caused by an altered growth dynamics of WS cells [46]), and deficiencies in re…”
BackgroundWerner and Hutchinson–Gilford progeria syndromes: mechanistic basis of human progeroid diseases
Kudlow, B. A., Kennedy, B. K., & Monnat, R. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2161 · Cited by 304 · cited 1×
“Such syndromes are studied not only because of their severity for the patient, leading in many cases to lifespan shortening, but also in the expectation that their study may identify causative genes involved in the mechanisms underlying normal ageing [2,3].”
BackgroundTelomere dysfunction as a cause of genomic instability in Werner syndrome
Crabbe, L., Jauch, A., Naeger, C. M., Holtgreve-Grez, H., & Karlseder, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609410104 · Cited by 240
Schulz, V. P., Zakian, V. A., Ogburn, C. E., McKay, J., Jarzebowicz, A. A., Martin, G. M., & Edland, S. D. (1996) · Human Genetics · doi:10.1007/bf02346184 · Cited by 221
Molecular bases of progeroid syndromes
Navarro, C. L., Cau, P., & Lévy, N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl214 · Cited by 189 · cited 1×
“Such syndromes are studied not only because of their severity for the patient, leading in many cases to lifespan shortening, but also in the expectation that their study may identify causative genes involved in the mechanisms underlying normal ageing [2,3].”
BackgroundThe Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro
Orren, D. K., Theodore, S., & Machwe, A. (2002) · Biochemistry · doi:10.1021/bi0266986 · Cited by 112 · cited 24×
“Many of these structures may form during, and thus impair, processes of DNA metabolism.”
BackgroundInfluentialDavis, T., Baird, D. M., Haughton, M. F., Jones, C. J., & Kipling, D. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1386 · Cited by 93
Self-citation
Cited by
Reversible Senescence in Human CD4+CD45RA+CD27− Memory T Cells
Di Mitri, D., Azevedo, R. I., Henson, S. M., Libri, V., Riddell, N. E., Macaulay, R., Kipling, D., Soares, M. V. D., Battistini, L., & Akbar, A. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100978 · Cited by 231
Self-citationOsteosarcoma: Molecular Pathogenesis and iPSC Modeling
Lin, Y.-H., Jewell, B. E., Gingold, J., Lu, L., Zhao, R., Wang, L. L., & Lee, D.-F. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.06.004 · Cited by 150
“p38 MAPK activation leads to accelerated cell senescence in WS fibroblasts, implying a potential therapeutic role for a p38 inhibitor inWS [71,72].”
BackgroundLambert, W. S., Pasini, S., Collyer, J. W., Formichella, C. R., Ghose, P., Carlson, B. J., & Calkins, D. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-65374-6 · Cited by 21
Computational modeling implicates protein scaffolding in p38 regulation of Akt
Kinnunen, P. C., Luker, G. D., Luker, K. E., & Linderman, J. J. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111294 · Cited by 4
Metadata
- Authors
- Bagley, M. C., Davis, T., Murziani, P. G. S., Widdowson, C. S., & Kipling, D.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2010-06-04
- Volume
- 3
- Issue
- 6
- Pages
- 1842-1872
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W2071561879
- Cited by
- 35
- References
- 13
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome. https://app.cochat.ai/papers/10.3390/ph3061842
- The paper
- Bagley, M. C., Davis, T., Murziani, P. G. S., Widdowson, C. S., & Kipling, D. (2010). Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome. Pharmaceuticals. https://doi.org/10.3390/ph3061842
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.